Cargando…

NF-Y subunits overexpression in gastric adenocarcinomas (STAD)

NF-Y is a pioneer transcription factor—TF—formed by the Histone-like NF-YB/NF-YC subunits and the regulatory NF-YA. It binds to the CCAAT box, an element enriched in promoters of genes overexpressed in many types of cancer. NF-YA is present in two major isoforms—NF-YAs and NF-YAl—due to alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Alberto, Ronzio, Mirko, Bezzecchi, Eugenia, Mantovani, Roberto, Dolfini, Diletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660849/
https://www.ncbi.nlm.nih.gov/pubmed/34887475
http://dx.doi.org/10.1038/s41598-021-03027-y
_version_ 1784613278768431104
author Gallo, Alberto
Ronzio, Mirko
Bezzecchi, Eugenia
Mantovani, Roberto
Dolfini, Diletta
author_facet Gallo, Alberto
Ronzio, Mirko
Bezzecchi, Eugenia
Mantovani, Roberto
Dolfini, Diletta
author_sort Gallo, Alberto
collection PubMed
description NF-Y is a pioneer transcription factor—TF—formed by the Histone-like NF-YB/NF-YC subunits and the regulatory NF-YA. It binds to the CCAAT box, an element enriched in promoters of genes overexpressed in many types of cancer. NF-YA is present in two major isoforms—NF-YAs and NF-YAl—due to alternative splicing, overexpressed in epithelial tumors. Here we analyzed NF-Y expression in stomach adenocarcinomas (STAD). We completed the partitioning of all TCGA tumor samples (450) according to molecular subtypes proposed by TCGA and ACRG, using the deep learning tool DeepCC. We analyzed differentially expressed genes—DEG—for enriched pathways and TFs binding sites in promoters. CCAAT is the predominant element only in the core group of genes upregulated in all subtypes, with cell-cycle gene signatures. NF-Y subunits are overexpressed, particularly NF-YA. NF-YAs is predominant in CIN, MSI and EBV TCGA subtypes, NF-YAl is higher in GS and in the ACRG EMT subtypes. Moreover, NF-YAl(high) tumors correlate with a discrete Claudin(low) cohort. Elevated NF-YB levels are protective in MSS;TP53(+) patients, whereas high NF-YAl/NF-YAs ratios correlate with worse prognosis. We conclude that NF-Y isoforms are associated to clinically relevant features of gastric cancer.
format Online
Article
Text
id pubmed-8660849
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86608492021-12-13 NF-Y subunits overexpression in gastric adenocarcinomas (STAD) Gallo, Alberto Ronzio, Mirko Bezzecchi, Eugenia Mantovani, Roberto Dolfini, Diletta Sci Rep Article NF-Y is a pioneer transcription factor—TF—formed by the Histone-like NF-YB/NF-YC subunits and the regulatory NF-YA. It binds to the CCAAT box, an element enriched in promoters of genes overexpressed in many types of cancer. NF-YA is present in two major isoforms—NF-YAs and NF-YAl—due to alternative splicing, overexpressed in epithelial tumors. Here we analyzed NF-Y expression in stomach adenocarcinomas (STAD). We completed the partitioning of all TCGA tumor samples (450) according to molecular subtypes proposed by TCGA and ACRG, using the deep learning tool DeepCC. We analyzed differentially expressed genes—DEG—for enriched pathways and TFs binding sites in promoters. CCAAT is the predominant element only in the core group of genes upregulated in all subtypes, with cell-cycle gene signatures. NF-Y subunits are overexpressed, particularly NF-YA. NF-YAs is predominant in CIN, MSI and EBV TCGA subtypes, NF-YAl is higher in GS and in the ACRG EMT subtypes. Moreover, NF-YAl(high) tumors correlate with a discrete Claudin(low) cohort. Elevated NF-YB levels are protective in MSS;TP53(+) patients, whereas high NF-YAl/NF-YAs ratios correlate with worse prognosis. We conclude that NF-Y isoforms are associated to clinically relevant features of gastric cancer. Nature Publishing Group UK 2021-12-09 /pmc/articles/PMC8660849/ /pubmed/34887475 http://dx.doi.org/10.1038/s41598-021-03027-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Gallo, Alberto
Ronzio, Mirko
Bezzecchi, Eugenia
Mantovani, Roberto
Dolfini, Diletta
NF-Y subunits overexpression in gastric adenocarcinomas (STAD)
title NF-Y subunits overexpression in gastric adenocarcinomas (STAD)
title_full NF-Y subunits overexpression in gastric adenocarcinomas (STAD)
title_fullStr NF-Y subunits overexpression in gastric adenocarcinomas (STAD)
title_full_unstemmed NF-Y subunits overexpression in gastric adenocarcinomas (STAD)
title_short NF-Y subunits overexpression in gastric adenocarcinomas (STAD)
title_sort nf-y subunits overexpression in gastric adenocarcinomas (stad)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660849/
https://www.ncbi.nlm.nih.gov/pubmed/34887475
http://dx.doi.org/10.1038/s41598-021-03027-y
work_keys_str_mv AT galloalberto nfysubunitsoverexpressioningastricadenocarcinomasstad
AT ronziomirko nfysubunitsoverexpressioningastricadenocarcinomasstad
AT bezzecchieugenia nfysubunitsoverexpressioningastricadenocarcinomasstad
AT mantovaniroberto nfysubunitsoverexpressioningastricadenocarcinomasstad
AT dolfinidiletta nfysubunitsoverexpressioningastricadenocarcinomasstad